Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.
Enrolling by invitation · NCT07644403 · Registry updated 2026-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. | Epithelial Cancer Patients | Enrolling by invitation | Phase 1 / Phase 2 | 2026-06-12 | NCT07644403 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Immunofoco Biotechnology Co., Ltd | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 85 |